Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.9160
-0.0065 (-0.70%)
At close: Jun 27, 2025, 4:00 PM
0.9020
-0.0140 (-1.53%)
After-hours: Jun 27, 2025, 4:10 PM EDT

Barinthus Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
99.12110.66142.09194.39214.0543.27
Upgrade
Cash & Short-Term Investments
99.12110.66142.09194.39214.0543.27
Upgrade
Cash Growth
-23.74%-22.12%-26.90%-9.19%394.74%278.46%
Upgrade
Accounts Receivable
---5.850.020.52
Upgrade
Other Receivables
3.867.147.946.316.933.01
Upgrade
Receivables
3.867.147.9412.166.953.53
Upgrade
Prepaid Expenses
5.015.865.45.894.611.08
Upgrade
Restricted Cash
1.461.74----
Upgrade
Other Current Assets
0.440.341.470.611.150.03
Upgrade
Total Current Assets
109.88125.74156.91213.04226.7747.9
Upgrade
Property, Plant & Equipment
10.0611.7619.415.719.092.77
Upgrade
Goodwill
--12.2112.2112.63-
Upgrade
Other Intangible Assets
21.1621.9525.1128.2731.43-
Upgrade
Other Long-Term Assets
0.90.880.880.980.8-
Upgrade
Total Assets
142160.33214.51270.21280.7250.67
Upgrade
Accounts Payable
1.362.471.63.752.424.67
Upgrade
Accrued Expenses
7.29.539.218.067.882.54
Upgrade
Short-Term Debt
----0.16-
Upgrade
Current Portion of Leases
1.961.921.790.430.520.19
Upgrade
Current Unearned Revenue
1.461.74--0.180.25
Upgrade
Total Current Liabilities
11.9815.6612.612.2411.167.64
Upgrade
Long-Term Debt
-----44.7
Upgrade
Long-Term Leases
9.9610.0911.198.346.541.47
Upgrade
Long-Term Deferred Tax Liabilities
0.420.440.573.758.08-
Upgrade
Other Long-Term Liabilities
4.054.013.152.682.37-
Upgrade
Total Liabilities
26.430.1927.512728.1553.81
Upgrade
Common Stock
00000-
Upgrade
Additional Paid-In Capital
393.94393.47386.6379.5369.121.66
Upgrade
Retained Earnings
-257.31-237.66-176.59-103.24-108.59-57.72
Upgrade
Comprehensive Income & Other
-21.14-25.78-23.23-33.37-8.39-1.24
Upgrade
Total Common Equity
115.49130.03186.78242.9252.13-37.3
Upgrade
Minority Interest
0.10.110.210.310.440.39
Upgrade
Shareholders' Equity
115.59130.14187243.2252.56-3.15
Upgrade
Total Liabilities & Equity
142160.33214.51270.21280.7250.67
Upgrade
Total Debt
11.9212.0112.988.777.2246.36
Upgrade
Net Cash (Debt)
87.298.66129.11185.61206.83-3.1
Upgrade
Net Cash Growth
-25.58%-23.59%-30.44%-10.26%--
Upgrade
Net Cash Per Share
2.202.513.364.867.99-0.39
Upgrade
Filing Date Shares Outstanding
40.3440.3438.9238.3437.190.03
Upgrade
Total Common Shares Outstanding
40.3440.2338.6437.6837.190.03
Upgrade
Working Capital
97.91110.09144.31200.8215.6140.26
Upgrade
Book Value Per Share
2.863.234.836.456.78-1447.99
Upgrade
Tangible Book Value
94.34108.08149.47202.42208.07-37.3
Upgrade
Tangible Book Value Per Share
2.342.693.875.375.59-1447.99
Upgrade
Machinery
-7.516.845.352.091.06
Upgrade
Leasehold Improvements
-9.288.673.930.630.05
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q